More on TEM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $48.98 |
|
|||
| Open | $48.33 | ||||
| 52 Wk High | $0.45 | ||||
| 52 Wk Low | $0.37 | ||||
| Day High | $48.60 | ||||
| Day Low | $46.51 | ||||
| P/E | N/A | ||||
| EPS | $-0.31 | ||||
| Volume | 4,141,462 | ||||
- Tempus AI launches OneOme pharmacogenomics testing nationally
- Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine
- Form 8-K Tempus AI, Inc. For: Jul 20
- Jefferies Reiterates Underperform Rating on Tempus AI Inc (TEM)
- Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)
- Needham on Tempus AI Inc (TEM): 'Buyers of any weakness related to the transaction'
- PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus
- Needham Downgrades Personalis (PSNL) to Hold
- Form 425 Tempus AI, Inc. Filed by: Tempus AI, Inc.
- Form 8-K Tempus AI, Inc. For: Jul 20
Entities mentioned with TEM
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- James Beeland Rogers Jr. | View Related Stories »
- Twitter | View Related Stories »
- Show More...
